TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

Pomerantz LLP is investigating potential securities fraud claims against Soleno Therapeutics following a short seller report questioning the safety and pricing of its product Vykat XR. The company disclosed an 8% discontinuation rate due to adverse effects and acknowledged disruption to its product launch. Soleno's stock fell 7.41% after the initial report and 26.59% following the earnings disclosure.

Insights
SFTBY   neutral

Stock has given back recent gains but remains substantially up overall


SLNO   negative

Company faces securities fraud investigation, significant stock price declines (7.41% and 26.59%), disclosed high discontinuation rates of its primary product due to adverse effects, and acknowledged disruption to product launch following negative short seller report.